鋰 (藥物)
參考資料

↑  . Drugs.com.   [4 April 2017]. （原始内容存档于5 April 2017）.
1 2 3 4 5 6 7 8 9 10 11 12 13  . The American Society of Health-System Pharmacists.   [Dec 1, 2015]. （原始内容存档于2015-12-08）.
↑  Baldessarini, Ross J; Tondo, Leonardo; Davis, Paula; Pompili, Maurizio; Goodwin, Frederick K; Hennen, John. . Bipolar Disorders. 2006, 8 (5p2): 625–39. PMID 17042835. doi:10.1111/j.1399-5618.2006.00344.x.
↑  . LactMed. 2015-03-10  [1 December 2015]. （原始内容存档于8 December 2015）.
↑  Sneader, Walter.  Rev. and updated. Chichester: Wiley. 2005: 63. ISBN 9780471899792. （原始内容存档于2017-09-08）.
↑   (PDF). World Health Organization. April 2015  [8 December 2016]. （原始内容存档 (PDF)于13 December 2016）.
↑  . International Drug Price Indicator Guide.   [1 December 2015]. [永久]
↑  McKnight RF, de La Motte de Broöns de Vauvert SJ, Chesney E, Amit BH, Geddes J, Cipriani A. . The Cochrane Database of Systematic Reviews. June 2019, 2019 (6): CD004048. PMC 6544558 . PMID 31152444. doi:10.1002/14651858.CD004048.pub4.
↑  Rakofsky JJ, Lucido MJ, Dunlop BW. . Journal of Affective Disorders. July 2022, 308: 268–280. PMID 35429528. S2CID 248161621. doi:10.1016/j.jad.2022.04.058.
↑  Riedinger MA, van der Wee NJ, Giltay EJ, de Leeuw M. . Human Psychopharmacology. September 2023, 38 (5): e2881. PMID 37789577. doi:10.1002/hup.2881 . hdl:10067/2003410151162165141 .
↑  Cai L, Chen G, Yang H, Bai Y. . International Clinical Psychopharmacology. July 2023, 38 (4): 249–260. PMID 36947416. S2CID 257665886. doi:10.1097/YIC.0000000000000449.
↑  Rosenberg JM, Salzman C. . CNS Spectrums. November 2007, 12 (11): 831–841. PMID 17984856. S2CID 26227696. doi:10.1017/S1092852900015571.
↑  Frye MA, Salloum IM. . Bipolar Disorders. December 2006, 8 (6): 677–685. PMID 17156154. doi:10.1111/j.1399-5618.2006.00370.x.
↑  Vornik LA, Brown ES. . The Journal of Clinical Psychiatry. 2006, 67 (Suppl 7): 24–30. PMID 16961421.
↑  Nabi Z, Stansfeld J, Plöderl M, Wood L, Moncrieff J. . Epidemiology and Psychiatric Sciences. September 2022, 31: e65. PMC 9533115 . PMID 36111461. doi:10.1017/S204579602200049X .
↑  Bauer M, Adli M, Ricken R, Severus E, Pilhatsch M. . CNS Drugs. April 2014, 28 (4): 331–342. PMID 24590663. S2CID 256840. doi:10.1007/s40263-014-0152-8.
↑  Bauer M, Adli M, Baethge C, Berghöfer A, Sasse J, Heinz A, Bschor T. . Canadian Journal of Psychiatry. August 2003, 48 (7): 440–448. PMID 12971013. doi:10.1177/070674370304800703.
↑  Undurraga J, Sim K, Tondo L, Gorodischer A, Azua E, Tay KH, Tan D, Baldessarini RJ. . Journal of Psychopharmacology. February 2019, 33 (2): 167–176  [20 February 2024]. PMID 30698058. S2CID 59411183. doi:10.1177/0269881118822161. （原始内容存档于20 February 2024）.
↑  Crossley, NA; Bauer, M. . The Journal of clinical psychiatry. 2007-06, 68 (6): 935–40. PMID 17592920. doi:10.4088/jcp.v68n0617.
↑  Finley PR. . Clinical Pharmacokinetics. August 2016, 55 (8): 925–941. PMID 26936045. doi:10.1007/s40262-016-0370-y.
↑  Bauer M, Gitlin M. . . Cham: Springer International Publishing. 2016: 71–80. ISBN 978-3-319-31212-5. doi:10.1007/978-3-319-31214-9_7.
1 2  Haussmann R, Noppes F, Brandt MD, Bauer M, Donix M. . Neuroscience Letters. August 2021, 760: 136044. PMID 34119602. S2CID 235385875. doi:10.1016/j.neulet.2021.136044.
↑  Wei HF, Anchipolovsky S, Vera R, Liang G, Chuang DM. . European Review for Medical and Pharmacological Sciences. March 2022, 26 (6): 2201–2214. PMC 9173589 . PMID 35363371. doi:10.26355/eurrev_202203_28369.
↑  Moon, Woori; Ji, Eunjeong; Shin, Juyoung; Kwon, Jun Soo; Kim, Ki Woong. . Scientific Reports. 2022-08-19, 12 (1). doi:10.1038/s41598-022-18350-1.
↑
↑  Grandjean EM, Aubry JM. . CNS Drugs (Springer Science and Business Media LLC). 2009, 23 (4): 331–349. PMID 19374461. S2CID 38042857. doi:10.2165/00023210-200923040-00005.
↑  Solomon DA, Ristow WR, Keller MB, Kane JM, Gelenberg AJ, Rosenbaum JF, Warshaw MG. . The American Journal of Psychiatry. October 1996, 153 (10): 1301–1307. PMID 8831438. doi:10.1176/ajp.153.10.1301.
↑  Perlis RH, Sachs GS, Lafer B, Otto MW, Faraone SV, Kane JM, Rosenbaum JF. . The American Journal of Psychiatry. July 2002, 159 (7): 1155–1159. PMID 12091193. doi:10.1176/appi.ajp.159.7.1155.
1 2  Girardi, P; Brugnoli, R; Manfredi, G; Sani, G. . Drugs in R&D. 2016-12, 16 (4): 293–302. PMID 27770296. doi:10.1007/s40268-016-0139-7.
↑  Devanand, DP; Crocco, E; Forester, BP; Husain, MM; Lee, S; Vahia, IV; Andrews, H; Simon-Pearson, L; Imran, N; Luca, L; Huey, ED; Deliyannides, DA; Pelton, GH. . The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 2022-01, 30 (1): 32–42. PMID 34059401. doi:10.1016/j.jagp.2021.04.014.
1 2  Strawbridge R, Young AH. . International Journal of Bipolar Disorders. January 2024, 12 (1): 4. PMC 10828288 . PMID 38289425. doi:10.1186/s40345-024-00325-y . An in-depth recent study reported high interindividual variation but steeper declines in estimated glomerular filtration rate (eGFR) explained by lithium use but also found wrongful clinical attribution of some chronic kidney disease (CKD) cases to lithium (Fransson et al. 2022) which may have increased other records-based studies’ estimates (Strawbridge and Young 2022). [...]
1 2  Burdick, KE; Millett, CE; Russo, M; Alda, M; Alliey-Rodriguez, N; Anand, A; Balaraman, Y; Berrettini, W; Bertram, H; Calabrese, JR; Calkin, C; Conroy, C; Coryell, W; DeModena, A; Feeder, S; Fisher, C; Frazier, N; Frye, M; Gao, K; Garnham, J; Gershon, ES; Glazer, K; Goes, FS; Goto, T; Harrington, GJ; Jakobsen, P; Kamali, M; Kelly, M; Leckband, S; Løberg, EM; Lohoff, FW; Maihofer, AX; McCarthy, MJ; McInnis, M; Morken, G; Nievergelt, CM; Nurnberger, J; Oedegaard, KJ; Ortiz, A; Ritchey, M; Ryan, K; Schinagle, M; Schwebel, C; Shaw, M; Shilling, P; Slaney, C; Stapp, E; Tarwater, B; Zandi, P; Kelsoe, JR. . Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2020-09, 45 (10): 1743–1749. PMID 32349118. doi:10.1038/s41386-020-0683-2.
↑
↑  Nielsen J, Kwon TH, Christensen BM, Frøkiaer J, Nielsen S. . Seminars in Nephrology. May 2008, 28 (3): 227–244. PMID 18519084. doi:10.1016/j.semnephrol.2008.03.002.
1 2  Alexander MP, Farag YM, Mittal BV, Rennke HG, Singh AK. . Kidney International. January 2008, 73 (2): 233–237. PMID 17943083. doi:10.1038/sj.ki.5002578 .
↑  Sands JM, Bichet DG. . Annals of Internal Medicine. February 2006, 144 (3): 186–194. PMID 16461963. S2CID 6732380. doi:10.7326/0003-4819-144-3-200602070-00007.
↑  Garofeanu CG, Weir M, Rosas-Arellano MP, Henson G, Garg AX, Clark WF. . American Journal of Kidney Diseases. April 2005, 45 (4): 626–637. PMID 15806465. doi:10.1053/j.ajkd.2005.01.008.
↑  Presne C, Fakhouri F, Noël LH, Stengel B, Even C, Kreis H, Mignon F, Grünfeld JP. . Kidney International. August 2003, 64 (2): 585–592. PMID 12846754. doi:10.1046/j.1523-1755.2003.00096.x .
1 2 3  Kessing LV. . International Journal of Bipolar Disorders. January 2024, 12 (1): 3. PMC 10792154 . PMID 38228882. doi:10.1186/s40345-023-00322-7 .
↑  Davis J, Desmond M, Berk M. . Nephrology (Wiley). October 2018, 23 (10): 897–903. PMID 29607573. S2CID 4552345. doi:10.1111/nep.13263 . hdl:11343/283773 .
↑  Lambert CG, Mazurie AJ, Lauve NR, Hurwitz NG, Young SS, Obenchain RL, Hengartner NW, Perkins DJ, Tohen M, Kerner B. . Bipolar Disorders. May 2016, 18 (3): 247–260. PMC 5089566 . PMID 27226264. doi:10.1111/bdi.12391.
↑  . MGH Center for Women's Mental Health. 2021-03-04  [2024-12-05] （美国英语）.
↑  Poels EM, Bijma HH, Galbally M, Bergink V. . International Journal of Bipolar Disorders. December 2018, 6 (1): 26. PMC 6274637 . PMID 30506447. doi:10.1186/s40345-018-0135-7 .
↑  . reprotox.org.   [2024-12-05].
↑  . www.rcpsych.ac.uk.   [2024-12-05] （英语）.
↑  Armstrong C. . American Family Physician. 2008-09-15, 78 (6): 772–778 （美国英语）.
↑  Singh, S; Deep, R. . Indian journal of pharmacology. 2022-11, 54 (6): 443–451. PMC 10043818 . PMID 36722556. doi:10.4103/ijp.ijp_407_21.
↑  Poels, Eline M. P.; Kamperman, Astrid M.; Bijma, Hilmar H.; Honig, Adriaan; van Kamp, Inge L.; Kushner, Steven A.; Hoogendijk, Witte J. G.; Bergink, Veerle; White, Tonya. . Bipolar Disorders. 2023-05, 25 (3): 181–190. doi:10.1111/bdi.13297.
↑  . reprotox.org.   [2024-12-05].
↑  Nonacs R. . 2024-11-13  [2024-12-05] （美国英语）.
↑  . nhs.uk. 2023-08-14  [2024-12-05] （英语）.
↑  Gelder, M., Mayou, R. and Geddes, J. 2005. Psychiatry. 3rd ed. New York: Oxford. pp249.
↑  Adityanjee; Munshi, Thampy. . Clinical Neuropharmacology. 2005, 28 (1): 38–49. PMID 15714160. doi:10.1097/01.wnf.0000150871.52253.b7.
1 2  Malhi GS, Masson M, Bellivier F. . Springer International Publishing. 2017: 62. ISBN 978-3-319-45923-3. OCLC 979600268.
↑  Einat H, Manji HK. . Biological Psychiatry. June 2006, 59 (12): 1160–1171. PMID 16457783. S2CID 20669215. doi:10.1016/j.biopsych.2005.11.004.
↑  Gould TD, Picchini AM, Einat H, Manji HK. . Current Drug Targets. November 2006, 7 (11): 1399–1409. PMID 17100580. doi:10.2174/1389450110607011399.
↑  Böer U, Cierny I, Krause D, Heinrich A, Lin H, Mayr G, Hiemke C, Knepel W. . Neuropsychopharmacology. September 2008, 33 (10): 2407–2415. PMID 18046304. doi:10.1038/sj.npp.1301640 .
↑  Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yücel M, Gama CS, Dodd S, Dean B, Magalhães PV, Amminger P, McGorry P, Malhi GS. . Neuroscience and Biobehavioral Reviews. January 2011, 35 (3): 804–817. PMID 20934453. S2CID 11421586. doi:10.1016/j.neubiorev.2010.10.001.
1 2 3  Quiroz JA, Machado-Vieira R, Zarate CA, Manji HK. . Neuropsychobiology. 2010, 62 (1): 50–60. PMC 2889681 . PMID 20453535. doi:10.1159/000314310.
↑  Necus J, Sinha N, Smith FE, Thelwall PE, Flowers CJ, Taylor PN, Blamire AM, Cousins DA, Wang Y. . Journal of Affective Disorders. June 2019, 253: 224–231. PMC 6609924 . PMID 31054448. doi:10.1016/j.jad.2019.04.075.
↑  Malhi GS, Tanious M, Das P, Coulston CM, Berk M. . CNS Drugs. February 2013, 27 (2): 135–153. PMID 23371914. S2CID 26907074. doi:10.1007/s40263-013-0039-0. hdl:11343/218106 .
↑  Abu-Hijleh FA, Prashar S, Joshi H, Sharma R, Frey BN, Mishra RK. . Bipolar Disorders. February 2021, 23 (1): 76–83. PMID 33037686. S2CID 222257563. doi:10.1111/bdi.13019.
↑  Toledano E, Ogryzko V, Danchin A, Ladant D, Mechold U. . The Biochemical Journal. April 2012, 443 (2): 485–490. PMC 3316155 . PMID 22240080. doi:10.1042/BJ20111057.
↑  Ghasemi M, Sadeghipour H, Mosleh A, Sadeghipour HR, Mani AR, Dehpour AR. . European Neuropsychopharmacology. May 2008, 18 (5): 323–332. PMID 17728109. S2CID 44805917. doi:10.1016/j.euroneuro.2007.07.011.
↑  Ghasemi M, Raza M, Dehpour AR. . Journal of Psychopharmacology. April 2010, 24 (4): 585–594. PMID 19351802. S2CID 41634565. doi:10.1177/0269881109104845.
↑  Mutz, Julian; Wong, Win Lee Edwin; Powell, Timothy R.; Young, Allan H.; Dawe, Gavin S.; Lewis, Cathryn M. . GeroScience. 2024-03-28, 46 (6): 5981–5994. doi:10.1007/s11357-024-01142-y.
↑  Araldi, E; Jutzeler, CR; Ristow, M. . Aging. 2023-01-11, 15 (2): 421–440. PMID 36640269. doi:10.18632/aging.204476.
|  论 编 |
| --- | --- |
抗驚厥劑（英语：）:  卡马西平  拉莫三嗪  奥卡西平  丙戊酸鈉  Valnoctamide（英语：）  新丙戊酯  丙戊酸半鈉  丙戊酸  Valpromide（英语：） 
非典型抗精神病藥:  阿立哌唑  Cariprazine（英语：）  Clozapine  Lurasidone（英语：）  奥氮平 (+氟西汀)  帕利哌酮  喹硫平  利培酮  齊拉西酮 
其它藥劑:  氯胺酮  鋰 (藥理學) (乙酸锂, 碳酸锂, 氯化锂, 檸檬酸鋰, 氢氧化锂)  Ω-3脂肪酸